论文部分内容阅读
本文对120例难治性心衰患者随机分为观察组与对照组各60例,观察了开博通、多巴酚丁胺加氨酰心安治疗难治性心衰的效果,并就其作用机理进行了探讨。治疗方法:开博通12.5～25mg,每日二次;多巴酚丁胺80mg～160mg加10％葡萄糖500ml静滴,4～8μg/kg/分,七天为一疗程;氮酰心安6.25～25mg,每日二次,随心衰改善而减量或停药。以临床表现和心电图变化作为疗效评定指标。结果表明可明显改善心衰的临床症状,缩短病程,有效率85％,统计学处
In this paper, 120 patients with refractory heart failure were randomly divided into observation group and control group of 60 patients observed Kepong, dobutamine and aminoacyl treatment of refractory heart failure, and its role Mechanism is discussed. Treatment: open booster 12.5 ~ 25mg, twice daily; dobutamine 80mg ~ 160mg plus 10% glucose 500ml intravenous infusion, 4 ~ 8μg / kg / min, seven days for a course of treatment; , Twice daily, with heart failure and improvement or reduction or withdrawal. With clinical manifestations and ECG changes as indicators of curative effect. The results show that can significantly improve the clinical symptoms of heart failure, shorten the course of the disease, the effective rate of 85%, Statistics